Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes

Figure 1

Urinary NGAL concentrations at the beginning of the study (initial results) and after 1 year of nephroprotective treatment (control results) among 30 DKD patients with available follow-up data. Closed circles and solid lines represent patients with decreasing uNGAL; open squares and dashed lines represent patients with increasing uNGAL. For abbreviations, see Table 1.